Purdue's $8.3bn Settlement With DOJ Requires Reconstitution As Public Benefit Company

Purdue pleads guilty to three felony charges over marketing of OxyContin under settlement that requires Purdue to be dissolved and transformed into an entity that provides addiction and overdose medicines. Twenty-five state AGs oppose creation of a PBC, arguing Purdue should be sold to another company.

Purdue Pharma L.P.’s $8.3bn settlement with the US Department of Justice bolsters its efforts to emerge from bankruptcy as a new entity free of the liability from its opioid marketing.

The company has agreed to plead guilty to three felony counts, pay a criminal fine of $3.54bn plus $2bn in criminal forfeiture, and pay a civil settlement of $2.8 billion...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Pink Sheet